Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers

Chromosomal translocations are important drivers of haematological malignancies whereby proto-oncogenes are activated by juxtaposition with enhancers, often called enhancer hijacking. We analysed the epigenomic consequences of rearrangements between the super-enhancers of the immunoglobulin heavy locus (IGH) and proto-oncogene CCND1 that are common in B-cell malignancies. By integrating BLUEPRINT epigenomic data with DNA breakpoint detection, we characterised the normal chromatin landscape of the human IGH locus and its dynamics after pathological genomic rearrangement. We detected an H3K4me3 broad domain (BD) within the IGH locus of healthy B cells that was absent in samples with IGH-CCND1 translocations. The appearance of H3K4me3-BD over CCND1 in the latter was associated with overexpression and extensive chromatin accessibility of its gene body. We observed similar cancer-specific H3K4me3-BDs associated with hijacking of super-enhancers of other common oncogenes in B-cell (MAF, MYC and FGFR3/NSD2) and T-cell malignancies (LMO2, TLX3 and TAL1). Our analysis suggests that H3K4me3-BDs can be created by super-enhancers and supports the new concept of epigenomic translocation, where the relocation of H3K4me3-BDs from cell identity genes to oncogenes accompanies the translocation of super-enhancers.

[1]  B. Javierre,et al.  High-resolution simulations of chromatin folding at genomic rearrangements in malignant B cells provide mechanistic insights into proto-oncogene deregulation , 2022, bioRxiv.

[2]  R. O’Neill,et al.  Epigenetic maintenance of topological domains in the highly rearranged gibbon genome , 2018, Genome research.

[3]  Min Gyu Lee,et al.  MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes. , 2018, Molecular cell.

[4]  R. Månsson,et al.  Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma. , 2018, Blood.

[5]  Katherine S. Pollard,et al.  Chromatin features constrain structural variation across evolutionary timescales , 2018, Proceedings of the National Academy of Sciences.

[6]  Linden J. Gearing,et al.  Regulation of H3K4me3 at Transcriptional Enhancers Characterizes Acquisition of Virus-Specific CD8+ T Cell-Lineage-Specific Function. , 2017, Cell reports.

[7]  Hong Kee Tan,et al.  Super-Enhancers and Broad H3K4me3 Domains Form Complex Gene Regulatory Circuits Involving Chromatin Interactions , 2017, Scientific Reports.

[8]  D. Casero,et al.  The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation , 2017, Leukemia.

[9]  J. Mellor,et al.  Is H3K4me3 instructive for transcription activation? , 2017, BioEssays : news and reviews in molecular, cellular and developmental biology.

[10]  I. Petersen,et al.  Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking , 2016, Nature Genetics.

[11]  Steven J. M. Jones,et al.  The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery , 2016, Cell.

[12]  K. Seitz.  Mantelzell-Lymphom , 2016, Z Ultraschall in der Medizin.

[13]  Xiaoyu Chen,et al.  Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..

[14]  Xin Hu,et al.  Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex , 2016, Cell.

[15]  Aaron C. Daugherty,et al.  H3K4me3 Breadth Is Linked to Cell Identity and Transcriptional Consistency , 2014, Cell.

[16]  B. Nadel,et al.  Site- and allele-specific polycomb dysregulation in T-cell leukaemia , 2015, Nature Communications.

[17]  J. Lieb,et al.  What are super-enhancers? , 2014, Nature Genetics.

[18]  H. Kueh,et al.  A far downstream enhancer for murine Bcl11b controls its T-cell specific expression. , 2013, Blood.

[19]  J. V. van Dongen,et al.  Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia , 2013, Haematologica.

[20]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[21]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[22]  Roderic Guigó,et al.  The GEM mapper: fast, accurate and versatile alignment by filtration , 2012, Nature Methods.

[23]  S. Spicuglia,et al.  H3K4 tri‐methylation provides an epigenetic signature of active enhancers , 2011, The EMBO journal.

[24]  Salvatore Spicuglia,et al.  A unique H3K4me2 profile marks tissue-specific gene regulation. , 2010, Genome research.

[25]  R. Bataille,et al.  Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome. , 2007, Blood.

[26]  K. Stamatopoulos,et al.  Molecular analysis of bcl‐1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation , 1999, British journal of haematology.

[27]  F. Mills,et al.  Enhancer Complexes Located Downstream of Both Human Immunoglobulin Cα Genes , 1997, The Journal of experimental medicine.

[28]  B. Birshtein,et al.  Virtually identical enhancers containing a segment of homology to murine 3'IgH-E(hs1,2) lie downstream of human Ig C alpha 1 and C alpha 2 genes. , 1997, Journal of immunology.

[29]  M. Rots,et al.  Clinical Epigenetics , 2019 .

[30]  P. L. Bergsagel,et al.  Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. , 1999, Molecular cell.